These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7656857)

  • 41. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
    Larrey D
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
    [No Abstract]   [Full Text] [Related]  

  • 42. The emerging clinical significance of hepatitis C.
    Aach RD
    Hosp Pract (Off Ed); 1992 May; 27(5A):19-22. PubMed ID: 1583089
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment].
    Lidove O; Cacoub P; Hausfater P; Wechsler B; Frances C; Leger JM; Piette JC
    Gastroenterol Clin Biol; 1999 Mar; 23(3):403-6. PubMed ID: 10384347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response of chronic hepatitis C to interferon-alpha treatment and relationship with iron metabolism.
    Martín-Vivaldi R; Nogueras F; González A; Quintero D; Pinel LM; Castro T; Hernández A
    Rev Esp Enferm Dig; 1997 Jul; 89(7):523-30. PubMed ID: 9265838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern.
    Morosetti M; Sciarra G; Meloni C; Palmieri G; Palombo G; Taccone Gallucci M; Casciani CU
    Nephrol Dial Transplant; 1996 Mar; 11(3):532-4. PubMed ID: 8671827
    [No Abstract]   [Full Text] [Related]  

  • 46. [Is the treatment of chronic viral hepatitis C with interferon-alpha effective?].
    Beker S; Pujol FH; Beker B
    G E N; 1995; 49(2):165-9. PubMed ID: 8566691
    [No Abstract]   [Full Text] [Related]  

  • 47. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
    Tambini R; Quattrini A; Fracassetti O; Nemni R
    J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
    [No Abstract]   [Full Text] [Related]  

  • 48. A rational approach to hepatitis C.
    Mills P; McPeake J; McCruden E
    Practitioner; 1996 Mar; 240(1560):172-6. PubMed ID: 8710731
    [No Abstract]   [Full Text] [Related]  

  • 49. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mixed cryoglobulinemia and hepatitis C virus infection: value of the treatment with interferon].
    Revenga Arranz F; Sánchez Gómez F; Vanaclocha Sebastián F; Fuertes Ortiz A
    Med Clin (Barc); 1995 Feb; 104(7):279. PubMed ID: 7731298
    [No Abstract]   [Full Text] [Related]  

  • 51. Do you have hepatitis C?
    Hager M; Reibstein L
    Newsweek; 1998 May; 131(18):83. PubMed ID: 10178849
    [No Abstract]   [Full Text] [Related]  

  • 52. [Post-transfusion hepatitis C, its diagnosis and treatment].
    Takano S; Omata M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):510-4. PubMed ID: 7563809
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatitis C virus: implications to pediatric practice.
    A-Kader HH; Balistreri WF
    Pediatr Infect Dis J; 1993 Oct; 12(10):853-66; quiz 867. PubMed ID: 8284123
    [No Abstract]   [Full Text] [Related]  

  • 54. How should we treat hepatitis C in 1997?
    Williams CN
    Can J Gastroenterol; 1997; 11(4):291-2. PubMed ID: 9218852
    [No Abstract]   [Full Text] [Related]  

  • 55. [Case of post-transfusion viral hepatitis of the non-A, non-B type].
    Knap J; Karwowska S
    Pol Tyg Lek; 1982 Oct; 37(40):1209-10. PubMed ID: 6819554
    [No Abstract]   [Full Text] [Related]  

  • 56. Retreatment with interferon-alpha of chronic hepatitis C virus infection.
    Marcellin P; Boyer N; Pouteau M; Benhamou JP; Erlinger S
    Lancet; 1994 Sep; 344(8923):690-1. PubMed ID: 7915382
    [No Abstract]   [Full Text] [Related]  

  • 57. [Physiopathology and therapy of hepatitis C].
    Tsuji T
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):398-400. PubMed ID: 7686205
    [No Abstract]   [Full Text] [Related]  

  • 58. [The advances in the treatment of chronic hepatitis C with interferon].
    Liu TH; Fu XX; Tian GS
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):650-2. PubMed ID: 1306461
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis C serotype and response to interferon therapy.
    Chemello L; Alberti A; Rose K; Simmonds P
    N Engl J Med; 1994 Jan; 330(2):143. PubMed ID: 8259181
    [No Abstract]   [Full Text] [Related]  

  • 60. Chronic hepatitis C after renal transplantation. Treatment with alpha-interferon.
    Chan TM; Lok AS; Cheng IK; Ng IO
    Transplantation; 1993 Nov; 56(5):1095-8. PubMed ID: 8249107
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.